BUY Aequs Limited — Kavita Jain, Arihant Capital Markets
byKavita Jain, Arihant Capital MarketsHorizon: NA (inferred Swing (≤2wk))28 Sept 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
MACD above its signal line — bullish momentum
Technicals · macd·28 Sept · today
Aequs raises funds to accelerate aerospace business expansion, targets $450 million capex
NewsCnbc-Tv18·28 Sept · today
Past week's volume 2.5× the 30-day average
Technicals · volume·28 Sept · today
The board of Aequs Limited approved an equity infusion of INR 650 crore through warrants issued to the promoter group.
BSE · Company Update·25 Sept · 3d ago
Board approved preferential issue of warrants convertible into equity shares.
BSE · Company Update·25 Sept · 3d ago
Aequs board approves ₹650 cr equity infusion for capacity expansion
NewsHbl·26 Sept · 2d ago
Aequs board approves ₹650 crore preferential issue of warrants to promoter group
NewsCnbc-Tv18·25 Sept · 3d ago
Aequs Limited's Board approved a preferential issue of up to 28,071,690 warrants convertible into equity shares at INR 231.55 per warrant, aggregating to INR 6,499,999,819.50. An EGM will be convened
BSE · Board Meeting·25 Sept · 3d ago
Board meeting scheduled for 25/09/2026 to consider and approve a preferential issue.
BSE · Board Meeting·21 Sept · 1w ago
RSI at 74 — overbought territory
Technicals · rsi·28 Sept · today
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.